Clinical Trials in Atlanta

Showing 14641-14660 of 19,805 trials

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

NCT00515099

Antithymocyte globulin (e.g., Thymoglobulin®) is an antibody preparation that is commonly used to treat and prevent organ transplant rejection. The START trial aims to determine whether antithymocyte globulin (ATG) treatment can halt the progression of newly diagnosed type 1 diabetes when given within 12 weeks of disease diagnosis.

New-onset Type 1 Diabetes Mellitus

National Institute of Allergy and Infectious Diseases (NIAID)58 participantsStarted Aug 2007

Los Angeles, California, United States • Oakland, California, United States • San Diego, California, United States +6 more locations

TERMINATEDPhase 2< 1 mile

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

NCT02276560

The purpose of this research study is to determine whether giving cisplatin and nab-paclitaxel before surgery will reduce the presence of disease in certain areas of the lung at the time of surgery.

Stage IIIA Non-Small Cell Lung Cancer

UNC Lineberger Comprehensive Cancer Center1 participantsStarted Jan 2015

Tampa, Florida, United States • Atlanta, Georgia, United States • Kansas City, Kansas, United States +6 more locations

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

Find Trials by Condition in Atlanta

Ovarian Cancer Vaccine for Patients in Remission

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism

REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction

Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis

Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer

Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma

A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes

A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)

Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)

Dose-Escalation Study of GSK2126458

Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy

Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome

Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics

Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO

Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)